Nuvation Bio Inc. Annual Operating Income (Loss) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nuvation Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2023.
  • Nuvation Bio Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$48.1M, a 82.6% decline year-over-year.
  • Nuvation Bio Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$560M, a 442% decline year-over-year.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2023 was -$99.8M, a 16.6% increase from 2022.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2022 was -$120M, a 28.3% decline from 2021.
  • Nuvation Bio Inc. annual Operating Income (Loss) for 2021 was -$93.3M, a 114% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$99.8M +$19.9M +16.6% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 -$120M -$26.4M -28.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-29
2021 -$93.3M -$49.8M -114% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-15
2020 -$43.6M Jan 1, 2020 Dec 31, 2020 10-K 2022-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.